Download Free Sample Report

The global Human Leukocyte Antigen Testing market was valued at US$ 3.08 billion in 2023 and is projected to reach US$ 5.13 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes

A blood test equipment that identifies antigens on the surface of cells and tissues.
This report aims to provide a comprehensive presentation of the global market for Human Leukocyte Antigen Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Leukocyte Antigen Testing. This report contains market size and forecasts of Human Leukocyte Antigen Testing in global, including the following market information:

• Global Human Leukocyte Antigen Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global Human Leukocyte Antigen Testing Market Sales, 2019-2024, 2025-2030, (K Units)
• Global top five Human Leukocyte Antigen Testing companies in 2023 (%)

The global key manufacturers of Human Leukocyte Antigen Testing include Thermo Fisher Scientific, F. Hoffman-La Roche, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Immucor, CareDx, Becton Dickinson and Hologic, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Leukocyte Antigen Testing manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Leukocyte Antigen Testing Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Leukocyte Antigen Testing Market Segment Percentages, by Type, 2023 (%)

• Molecular Assay Technologies
• Non-molecular Assay Technologies

Global Human Leukocyte Antigen Testing Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Leukocyte Antigen Testing Market Segment Percentages, by Application, 2023 (%)

• Independent Reference Laboratories
• Hospitals & Transplant Centers
• Research Laboratories & Academic Institutes

Global Human Leukocyte Antigen Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Human Leukocyte Antigen Testing Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Human Leukocyte Antigen Testing revenues in global market, 2019-2024 (Estimated), ($ millions)
• Key companies Human Leukocyte Antigen Testing revenues share in global market, 2023 (%)
• Key companies Human Leukocyte Antigen Testing sales in global market, 2019-2024 (Estimated), (K Units)
• Key companies Human Leukocyte Antigen Testing sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• F. Hoffman-La Roche
• Bio-Rad Laboratories
• QIAGEN N.V.
• Illumina
• Immucor
• CareDx
• Becton Dickinson
• Hologic
• GenDx
• Biofortuna

Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Leukocyte Antigen Testing, market overview.
Chapter 2: Global Human Leukocyte Antigen Testing market size in revenue and volume.
Chapter 3: Detailed analysis of Human Leukocyte Antigen Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Leukocyte Antigen Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Leukocyte Antigen Testing capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.